The European Medicine Agency’s Brexit-related move to Amsterdam from its London office in March had already led to staff losses. Now the agency says they have seen further decline in the past few months and that it will be difficult to carry out its work program for the final quarter of 2019 particularly in view of the need to implement new legislation for veterinary medicines and medical devices and additional work that will create. Pink Sheet shares headcount totals from the beginning until now and details about the agency’s interim space until it moves into its permanent home.